ClinConnect ClinConnect Logo
Search / Trial NCT07011927

Extra-cochlear Electrode Placement at the Post-auricular Vagus Nerve in Cochlear Implantation

Launched by NYU LANGONE HEALTH · Jun 2, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a new way to place a special electrode during cochlear implant surgery, which is a procedure to help people with hearing loss. The researchers want to see if placing the electrode near a specific nerve called the post-auricular vagus nerve (also known as Arnold's nerve) can provide similar or better hearing outcomes compared to the traditional method of placing it under the temporalis muscle.

To participate in this study, you need to be planning to get a cochlear implant from Cochlear Americas and be willing to take part in the research. However, if you have had previous ear surgeries, certain ear malformations, or have already received a cochlear implant in the same ear, you won’t be eligible. The trial is open to people aged 65 to 74, and they want to include all genders. If you join, you will help researchers learn more about the best ways to improve hearing for future patients. Please note that the trial is not yet recruiting participants.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • will be undergoing surgery for a cochlear implant from Cochlear Americas
  • is willing to participate in the study
  • Exclusion Criteria:
  • has history of prior ear surgery, congenital ear malformation, or prior cochlear implantation in the ear to be implanted
  • pregnant, planning to become pregnant, or breastfeeding patients cannot undergo the standard-of-care implantation procedures required for participation in the study.

About Nyu Langone Health

NYU Langone Health is a premier academic medical center located in New York City, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, NYU Langone Health integrates cutting-edge scientific inquiry with patient-centered care, striving to develop new therapies and improve health outcomes across a wide range of medical conditions. The institution is dedicated to fostering collaboration among researchers, clinicians, and patients, ensuring rigorous adherence to ethical standards and regulatory guidelines in all clinical research initiatives. By leveraging its extensive resources and expertise, NYU Langone Health aims to contribute significantly to the advancement of medical knowledge and the enhancement of patient care.

Locations

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

J. Thomas Roland, Jr., MD

Principal Investigator

NYU Langone Health

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported